Inicio
Información del autor
Autor Lucero Castrillón de P. |
Documentos disponibles escritos por este autor (3)
Clasificado(s) por (Año de edición descendente) Refinar búsqueda
Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients / Hugo Trujillo Soto ; Gloria Isabel Mejía de Rodríguez ; Lucero Castrillón de P.
Título : Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients Tipo de documento : documento electrónico Autores : Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., Fecha de publicación : 1989 Títulos uniformes : Chemotherapy Idioma : Inglés (eng) Palabras clave : Aztreonam Aerobic gram-negative bacilli Monobactam antibiotic Pediatric infections Resumen : Aztreonam was administered to 20 children diagnosed as having any of the following infections: urinary tract infection, pneumonia, meningitis, and abscess of the appendix. Haemophilus influenzae, Escherichia coli, and Klebsiellapneumoniae were isolated. The minimum inhibitory concentrations of aztreonam for these bacteria ranged from 0.03 to 0.5 μg/ml. All patients were clinically and bacteriologically cured within 5–16 days of treatment. Six months after completion of therapy, patients who had had meningitis appeared to be free of any neurologic sequelae. The antibiotic was well tolerated by all patients. Mención de responsabilidad : Trujillo H. · Harry N. · Arango A. · Benitez G. · Restrepo F. · Mejia de R. G.I. Castrillón de P. A.L. Referencia : Chemotherapy. 1989;35 Suppl 1:25-30. DOI (Digital Object Identifier) : 10.1159/000238717 PMID : 2731447 En línea : https://www.karger.com/Article/Abstract/238717 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4354 Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients [documento electrónico] / Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., . - 1989.
Obra : Chemotherapy
Idioma : Inglés (eng)
Palabras clave : Aztreonam Aerobic gram-negative bacilli Monobactam antibiotic Pediatric infections Resumen : Aztreonam was administered to 20 children diagnosed as having any of the following infections: urinary tract infection, pneumonia, meningitis, and abscess of the appendix. Haemophilus influenzae, Escherichia coli, and Klebsiellapneumoniae were isolated. The minimum inhibitory concentrations of aztreonam for these bacteria ranged from 0.03 to 0.5 μg/ml. All patients were clinically and bacteriologically cured within 5–16 days of treatment. Six months after completion of therapy, patients who had had meningitis appeared to be free of any neurologic sequelae. The antibiotic was well tolerated by all patients. Mención de responsabilidad : Trujillo H. · Harry N. · Arango A. · Benitez G. · Restrepo F. · Mejia de R. G.I. Castrillón de P. A.L. Referencia : Chemotherapy. 1989;35 Suppl 1:25-30. DOI (Digital Object Identifier) : 10.1159/000238717 PMID : 2731447 En línea : https://www.karger.com/Article/Abstract/238717 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4354 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000855 AC-1989-004 Archivo digital Producción Científica Artículos científicos Disponible Bacteriology of middle ear fluid specimens obtained by tympanocentesis from 111 Colombian children with acute otitis media / Hugo Trujillo Soto ; Ricardo Callejas ; Gloria Isabel Mejía de Rodríguez ; Lucero Castrillón de P.
Título : Bacteriology of middle ear fluid specimens obtained by tympanocentesis from 111 Colombian children with acute otitis media Tipo de documento : documento electrónico Autores : Hugo Trujillo Soto, ; Ricardo Callejas, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., Fecha de publicación : 1989 Títulos uniformes : Pediatric Infectious Disease Journal Idioma : Inglés (eng) Resumen : We cultured middle ear fluid specimens obtained by tympanocentesis from 111 Colombian infants and children, ages 11 days to 11 years, with acute otitis media. Bacteria were isolated in 82 patients (7.4%). Haemophilus influenzae, the most common isolate, was present in 40 cases (36%); 32 were nontypable strains and 8 were type b. Streptococcus pneumoniae, identified in 26 cases (22%), was the second most common pathogen. All H. influenzae and S. pneumoniae strains were susceptible to ampicillin and penicillin, respectively. We conclude that amoxicillin remains the drug of choice for treatment of acute otitis media in our country. Mención de responsabilidad : Trujillo Hugo MD; Callejas, Ricardo MD; Mejía, Gloria I.; Castrillón, Lucero Referencia : Pediatr Infect Dis J. 1989 Jun;8(6):361-3 DOI (Digital Object Identifier) : 10.1097/00006454-198906000-00007 PMID : 2787494 En línea : https://journals.lww.com/pidj/pages/articleviewer.aspx?year=1989&issue=06000&art [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4351 Bacteriology of middle ear fluid specimens obtained by tympanocentesis from 111 Colombian children with acute otitis media [documento electrónico] / Hugo Trujillo Soto, ; Ricardo Callejas, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., . - 1989.
Obra : Pediatric Infectious Disease Journal
Idioma : Inglés (eng)
Resumen : We cultured middle ear fluid specimens obtained by tympanocentesis from 111 Colombian infants and children, ages 11 days to 11 years, with acute otitis media. Bacteria were isolated in 82 patients (7.4%). Haemophilus influenzae, the most common isolate, was present in 40 cases (36%); 32 were nontypable strains and 8 were type b. Streptococcus pneumoniae, identified in 26 cases (22%), was the second most common pathogen. All H. influenzae and S. pneumoniae strains were susceptible to ampicillin and penicillin, respectively. We conclude that amoxicillin remains the drug of choice for treatment of acute otitis media in our country. Mención de responsabilidad : Trujillo Hugo MD; Callejas, Ricardo MD; Mejía, Gloria I.; Castrillón, Lucero Referencia : Pediatr Infect Dis J. 1989 Jun;8(6):361-3 DOI (Digital Object Identifier) : 10.1097/00006454-198906000-00007 PMID : 2787494 En línea : https://journals.lww.com/pidj/pages/articleviewer.aspx?year=1989&issue=06000&art [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4351 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000852 AC-1989-001 Archivo digital Producción Científica Artículos científicos Disponible In vitro evaluation of lomefloxacin activity in Colombia / Hugo Trujillo Soto ; Gloria Isabel Mejía de Rodríguez ; Lucero Castrillón de P. ; C. Gómez
Título : In vitro evaluation of lomefloxacin activity in Colombia Tipo de documento : documento electrónico Autores : Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., ; C. Gómez, Fecha de publicación : 1989 Títulos uniformes : Diagnostic Microbiology and Infectious Disease Idioma : Inglés (eng) Resumen : As part of the worldwide in vitro program to determine the antimicrobial activity of lomefloxacin, our study tested susceptibility of bacterial isolates from hospitals in Medellin, Colombia. A total of 504 bacterial isolates were obtained from patients at three different centers. For Enterobacteriaceae, 0.5 μg/ml inhibited 100% of the indole-positive Proteus and Salmonella spp.; 1 μg/ml inhibited 100% of Shigella and Citrobacter, 2 μg/ml inhibited 100% of Enterobacter spp., E. coli, Proteus mirabilis, and Serratia marcescens isolates tested. The MIC90 for Klebsiella spp. and Pseudomonas spp. was 4 μg/ml. The MIC90 was 4 μg/ml for S. aureus and 2 μg/ml for S. epidemidis and S. saprophyticus. The MIC90 of Streptococcus spp. were ⩽4 μg/ml for all isolates tested. Considering that 97.8% were susceptible to concentrations of ⩽4 μg/ml of lomefloxacin, this new quinolone offers potential in the therapy of a variety of systemic infections, especially in patients with multiply resistant pathogens. Mención de responsabilidad : H Trujillo, G I Mejia, L Castrillon, C Gomez Referencia : Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):51S-52S DOI (Digital Object Identifier) : 10.1016/0732-8893(89)90066-7 PMID : 2791498 En línea : https://linkinghub.elsevier.com/retrieve/pii/0732889389900667 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4352 In vitro evaluation of lomefloxacin activity in Colombia [documento electrónico] / Hugo Trujillo Soto, ; Gloria Isabel Mejía de Rodríguez, ; Lucero Castrillón de P., ; C. Gómez, . - 1989.
Obra : Diagnostic Microbiology and Infectious Disease
Idioma : Inglés (eng)
Resumen : As part of the worldwide in vitro program to determine the antimicrobial activity of lomefloxacin, our study tested susceptibility of bacterial isolates from hospitals in Medellin, Colombia. A total of 504 bacterial isolates were obtained from patients at three different centers. For Enterobacteriaceae, 0.5 μg/ml inhibited 100% of the indole-positive Proteus and Salmonella spp.; 1 μg/ml inhibited 100% of Shigella and Citrobacter, 2 μg/ml inhibited 100% of Enterobacter spp., E. coli, Proteus mirabilis, and Serratia marcescens isolates tested. The MIC90 for Klebsiella spp. and Pseudomonas spp. was 4 μg/ml. The MIC90 was 4 μg/ml for S. aureus and 2 μg/ml for S. epidemidis and S. saprophyticus. The MIC90 of Streptococcus spp. were ⩽4 μg/ml for all isolates tested. Considering that 97.8% were susceptible to concentrations of ⩽4 μg/ml of lomefloxacin, this new quinolone offers potential in the therapy of a variety of systemic infections, especially in patients with multiply resistant pathogens. Mención de responsabilidad : H Trujillo, G I Mejia, L Castrillon, C Gomez Referencia : Diagn Microbiol Infect Dis. 1989 May-Jun;12(3 Suppl):51S-52S DOI (Digital Object Identifier) : 10.1016/0732-8893(89)90066-7 PMID : 2791498 En línea : https://linkinghub.elsevier.com/retrieve/pii/0732889389900667 Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=4352 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000853 AC-1989-002 Archivo digital Producción Científica Artículos científicos Disponible